이주상 (성균관대학교 의과대학/인공지능학과 NextGen Medicine Lab)님 | 한빛사연구자 > 한빛사

성균관대학교 의과대학/인공지능학과 NextGen Medicine Lab

CV File

유전 및 유전체의학

최종업데이트 2024.01.17.

Herpes simplex virus 1 harboring poly(T) DNA sequences as a key ligand for AIM2 inflammasome activation and host defense
- Nat. Commun., 13 April 2026 | https://doi.org/10.1038/s41467-026-71896-w
- 2026-04
- 생명과학
- 한빛사논문
- 이주상(성균관대학교 의과대학/인공지능학과 NextGen Medicine Lab)
A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing
- Nat. Commun., Published 11 November 2021 | https://doi.org/10.1038/s41467-021-26788-6
- 2021-11
- 의약학
- 한빛사논문
- 이주상(성균관대학교 의과대학, National Cancer Institute)
Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma
- Nat. Commun., Published: 14 February 2020, 11, Article number: 896 | https://doi.org/10.1038/s41467-020-14639-9
- 2020-02
- 의약학
- 한빛사논문
- 이주상(성균관대학교 의과대학, 삼성서울병원, National Institute of Health)
  Interview 1
Synthetic lethality-mediated precision oncology via the tumor transcriptome
- Cell, Available online 14 April 2021 | https://doi.org/10.1016/j.cell.2021.03.030
- 2021-04
- 의약학
- 한빛사논문
- 이주상(National Institute of Health)
Multiomics Prediction of Response Rates to Therapies to Inhibit Programmed Cell Death 1 and Programmed Cell Death 1 Ligand 1
- JAMA Oncol., Published online August 22, 2019 | doi:10.1001/jamaoncol.2019.2311
- 2019-08
- 의약학
- 한빛사논문
- 이주상(National Institute of Health, University of Maryland)
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
- Cancer Cell, Published: February 14, 2019 | DOI:https://doi.org/10.1016/j.ccell.2019.01.009
- 2019-02
- 의약학
- 한빛사논문
- 이주상(National Institute of Health, University of Maryland)
Urea Cycle Dysregulation Generates Clinically Relevant Genomic and Biochemical Signatures
- Cell, Published:August 09, 2018 | DOI:https://doi.org/10.1016/j.cell.2018.07.019
- 2018-08
- 의약학
- 한빛사논문
- 이주상(University of Maryland, National Institute of Health)
Harnessing synthetic lethality to predict the response to cancer treatment
- Nat. Commun., Published: 29 June 2018, 9, Article number: 2546 | DOI: https://doi.org/10.1038/s41467-018-04647-1
- 2018-06
- 의약학
- 한빛사논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기